ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3158

What Predicts Absence of Spinal Damage in Patients with Spondyloarthritis after Prolonged Follow up?

Walter Maksymowych1, Stephanie Wichuk1, Praveena Chiowchanwisawakit2, Robert G Lambert3 and Susanne J Pedersen4, 1Medicine, University of Alberta, Edmonton, AB, Canada, 2Medicine, Mahidol University, Bangkok, Thailand, 3Radiology, University of Alberta, Edmonton, AB, Canada, 4Rheumatology, Copenhagen University Hospitals, Copenhagen, Denmark

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Magnetic resonance imaging (MRI), prognostic factors and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 16, 2016

Title: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment V: Imaging of Spondyloarthritis

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: After 20 years of follow up the majority of patients with aspondyloarthritis (SpA) have developed new bone in the spine although disease may remain isolated in the sacroiliac joints (SIJ) without any new bone in the spine. Assessment of these patients may provide new insights into the factors that influence disease progression. A new hypothesis has proposed that MRI can identify a “progressive phenotype” in early SpA characterized by the appearance of fat metaplasia in the SIJ. Fat metaplasia can occur both in subchondral bone and at the site of erosion after resolution of inflammation, this being termed backfill. We aimed to determine which clinical and MRI lesions in the SIJ are associated with absence of spinal damage after prolonged duration of symptoms.

Methods: In the FORCAST prospective cohort, AS patients (n=431) attending community and academic practices were assessed for clinical and laboratory outcomes every 6 months, radiography every 2 years, and MRI annually. MR scans of the SIJ were assessed by Spondyloarthritis Research Consortium of Canada (SPARCC) SIJ and Sacroiliac Structural Score (SSS) methods for inflammation and structural features, respectively, by 2 readers. Absence of spinal damage was pre-specified as no syndesmophytes or ankylosis on cervical and lumbar spine radiographs after ≥10 years from onset of symptoms and for the entire duration of prospective follow up. Patients with and without spinal damage were matched for age and symptom duration and compared by t-test, Mann-Whitney, and Fisher’s exact tests. We used univariate and multivariate conditional logistic regression to determine which demographic, clinical, and imaging variables were associated with absence of spinal damage.

Results: Mean (SD) duration of symptoms and prospective follow up was 18.0(7.0) and 2.3 (0.49) years in cases with no damage (n=42) and 17.5(8.2) and 2.6 (1.4) years in those with damage (n=81). The group with no damage had fewer males (p=0.004), lower CRP (p=0.02), and lower MRI SIJ scores for fat (p=0.03) and ankylosis (p=0.003) while score for SIJ erosion was significantly higher (p=0.02). Definite SIJ ankylosis (SSS score ≥2 by both readers) was evident in 20.7% of cases in the no damage group versus 53.3% of those with damage (p=0.007). Univariate regression indicated that no damage was associated with female sex (p=0.002), lower ASDAS (p=0.048), and lower SSS values for fat (p=0.032), backfill (p=0.014), and ankylosis (p=0.001). Smoking and B27 were not significant. A multivariate logistic regression model that included gender, ASDAS, and MRI SIJ features indicated that lower values for SSS backfill and ankylosis were independently associated with no damage (OR [95%CI]= 0.83 [0.69-0.99] and 0.89 [0.82-0.96], respectively). When all definite MRI features (SSS score ≥2 by both readers) were included in the model, definite SIJ ankylosis was significantly less likely in those who did not develop spinal damage (OR [95%CI]= 0.24 [0.08-0.70].

Conclusion: The absence of radiographic damage in the spine after prolonged duration of symptoms is associated with the lack of fat metaplasia and ankylosis in the SIJ on MRI. This supports the hypothesis that fat metaplasia identifies a progressive phenotype.


Disclosure: W. Maksymowych, Abbvie, 2,Janssen Pharmaceutica Product, L.P., 2,Pfizer Inc, 2,Sanofi-Aventis Pharmaceutical, 2,Abbvie, 5,Boehringer Ingelheim, 5,Eli Lilly and Company, 5,Celgene, 5,Novartis Pharmaceutical Corporation, 5,Pfizer Inc, 5,Sanofi-Aventis Pharmaceutical, 5,UCB, 5,Amgen, 5; S. Wichuk, None; P. Chiowchanwisawakit, None; R. G. Lambert, BioClinica, 5,Abbvie, 8; S. J. Pedersen, None.

To cite this abstract in AMA style:

Maksymowych W, Wichuk S, Chiowchanwisawakit P, Lambert RG, Pedersen SJ. What Predicts Absence of Spinal Damage in Patients with Spondyloarthritis after Prolonged Follow up? [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/what-predicts-absence-of-spinal-damage-in-patients-with-spondyloarthritis-after-prolonged-follow-up/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/what-predicts-absence-of-spinal-damage-in-patients-with-spondyloarthritis-after-prolonged-follow-up/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology